ATE64527T1 - Verfahren zur herstellung von vitaminpraeparaten. - Google Patents

Verfahren zur herstellung von vitaminpraeparaten.

Info

Publication number
ATE64527T1
ATE64527T1 AT87105082T AT87105082T ATE64527T1 AT E64527 T1 ATE64527 T1 AT E64527T1 AT 87105082 T AT87105082 T AT 87105082T AT 87105082 T AT87105082 T AT 87105082T AT E64527 T1 ATE64527 T1 AT E64527T1
Authority
AT
Austria
Prior art keywords
manufacture
vitamin preparations
preparations
beadlets
carotenoids
Prior art date
Application number
AT87105082T
Other languages
English (en)
Inventor
Leonard Joseph Scialpi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8196899&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE64527(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE64527T1 publication Critical patent/ATE64527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87105082T 1987-04-06 1987-04-06 Verfahren zur herstellung von vitaminpraeparaten. ATE64527T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87105082A EP0285682B2 (de) 1987-04-06 1987-04-06 Verfahren zur Herstellung von Vitaminpräparaten

Publications (1)

Publication Number Publication Date
ATE64527T1 true ATE64527T1 (de) 1991-07-15

Family

ID=8196899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87105082T ATE64527T1 (de) 1987-04-06 1987-04-06 Verfahren zur herstellung von vitaminpraeparaten.

Country Status (3)

Country Link
EP (1) EP0285682B2 (de)
AT (1) ATE64527T1 (de)
DE (1) DE3770940D1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
DE4141351A1 (de) * 1991-12-14 1993-06-17 Basf Ag Stabile pulverfoermige vitamin- und/oder carotinoid-praeparate und verfahren zu deren herstellung
DE4221880A1 (de) * 1992-07-03 1994-01-05 Alfatec Pharma Gmbh Feste und flüssige Lösungen von schwer wasserlöslichen Arzneistoffen
US5270063A (en) * 1992-08-03 1993-12-14 Kellogg Company Ready-to-eat cereal products enriched with beta-carotene
FR2703263B1 (fr) * 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
FR2707184B1 (fr) * 1993-07-08 1995-08-11 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules contenant un principe actif alimentaire ou pharmaceutique.
US5532009A (en) * 1995-06-07 1996-07-02 The Procter & Gamble Company Fat substitutes containing water soluble beta-carotene
DE19642359A1 (de) 1996-10-14 1998-04-16 Basf Ag Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
US6444227B1 (en) * 1999-08-05 2002-09-03 Roche Vitamins Inc. Process for preparing fat soluble beadlets
EP1244472B1 (de) 1999-12-23 2005-06-08 Adisseo France S.A.S. Teilchenförmige vitaminzubereitung
JP3935876B2 (ja) * 2001-08-23 2007-06-27 ディーエスエム アイピー アセッツ ビー．ブイ． 新規安定化カロテノイド組成物
CN1764439B (zh) 2003-03-27 2010-05-26 帝斯曼知识产权资产管理有限公司 制备交联明胶珠粒的方法
US10463061B2 (en) 2004-11-19 2019-11-05 Dsm Ip Assets B.V. Modified plant gums for preparations of active ingredients
RU2290173C2 (ru) * 2005-04-04 2006-12-27 Открытое акционерное общество "Научно-исследовательский институт технологий медицинской промышленности" (ОАО"НИИ ТМП") Способ получения стабильных сухих порошков жирорастворимых витаминов или каротиноидов
EP2210593A3 (de) 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettierbare Formulierungen von Vitamin A und Derivate davon
FR2953409B1 (fr) 2009-12-09 2011-12-23 Adisseo France Sas Particules de principes actifs liposolubles stables
EP2532354A1 (de) 2011-06-08 2012-12-12 OrganoBalance GmbH Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori
ES2600963T3 (es) 2011-06-08 2017-02-13 Novozymes A/S Células/Cepas Lactobacillus secadas por pulverización y su uso contra Helicobacter pylori
US11419820B2 (en) 2016-03-30 2022-08-23 Riken Vitamin Co., Ltd. Carotenoid-containing particles
GB201911925D0 (en) 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections
FR3111051A1 (fr) 2020-06-05 2021-12-10 Adisseo France S.A.S. Formulation de vitamine a
EP4250961A1 (de) * 2020-11-30 2023-10-04 DSM IP Assets B.V. Neue formulierungen mit reduziertem antioxidantgehalt, ihre herstellung und verwendung
WO2022112585A1 (en) * 2020-11-30 2022-06-02 Dsm Ip Assets B.V. New sugar-free formulations, their manufacture and use
WO2022112592A1 (en) * 2020-11-30 2022-06-02 Dsm Ip Assets B.V. New formulations with reduced antioxidant content, their manufacture and use
WO2022038588A2 (en) 2021-12-23 2022-02-24 Novozymes A/S Process for producing dried lactobacillus cells
EP4680205A1 (de) 2023-03-14 2026-01-21 DSM IP Assets B.V. Cannabinoidformulierungen
AU2024237033A1 (en) 2023-03-14 2025-09-04 Dsm Ip Assets B.V. Cannabinoid formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756177A (en) * 1953-03-09 1956-07-24 Hoffmann La Roche Process for making fat-soluble vitamin active powder
FR1287716A (fr) * 1960-04-07 1962-03-16 Philips Nv Procédé de préparation d'un produit sec épandable, contenant une substance biologique active
US3749799A (en) * 1972-02-04 1973-07-31 Hoffmann La Roche Stable dry vitamin a preparations

Also Published As

Publication number Publication date
EP0285682A1 (de) 1988-10-12
EP0285682B1 (de) 1991-06-19
DE3770940D1 (de) 1991-07-25
EP0285682B2 (de) 1997-08-06

Similar Documents

Publication Publication Date Title
ATE64527T1 (de) Verfahren zur herstellung von vitaminpraeparaten.
DE3675796D1 (de) Verfahren zur herstellung von entschleimten pflanzlichen oelen und schleim mit hohem gehalt an phosphatidischer saeure.
DE69224124D1 (de) Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid
DE3762630D1 (de) Verfahren zur herstellung von diperoxidodecandionsaeure enthaltenden agglomeraten und die verwendung derselben in bleichmitteln.
DE3382156D1 (de) Verwendung von 8-substituierten guanosinderivaten enthaltenden zusammensetzungen zur herstellung von arzneimitteln.
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
DE58906574D1 (de) Verfahren zur Herstellung von cyclischen Kohlensäureestern.
DE3784391D1 (de) Verfahren zur herstellung von eine oelloesliche substanz enthaltenden festen produkten.
DE3884870D1 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
DE3784392D1 (de) Verfahren zur herstellung von eine oelloesliche substanz enthaltenden festen produkten.
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
PT81875A (de) Verfahren zur herstellung von 13beta-alkyl-milbemycinderivaten und verfahren zur bekampfung von parasiten an tieren und pflanzen
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
DE3650643D1 (de) Verfahren zur Herstellung von 3-Polyfluoroalkylisoxazolylaminen
AU2072088A (en) Agent containing salicylic acid for treating lepidosis
ATA294581A (de) Verfahren zur herstellung von karamelpraeparaten in gepulverter form
DE58903882D1 (de) Muttersteckerteil zur gleichzeitigen herstellung von stark- und schwachstrom-steckverbindungen.
IE44288L (en) Preparation of amino acid mixture.
ATA297985A (de) Verfahren zur herstellung von bis-indolverbindungen enthaltenden stabilen waesserigen arzneimittelpraeparaten
ATE41740T1 (de) Verfahren zur retardierung von vitamin c und e.
DE3888307D1 (de) Verfahren zur Herstellung von Ascorbinsäure-2-phosphat.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
DE3850601D1 (de) Verfahren zur Herstellung von Phospholipidderivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee